Features

Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the World Pharmaceutical Frontiers editorial team, identify the main drivers of the industry helping to produce regular, thought-provoking opinion pieces on the latest issues, challenges and developments.

Latest World Pharmaceuticals Feature

What it says on the tin - multilingual packaging
21 February, 2017
How do you simplify labels to increase efficiency, while...
> read more
Design on trial – immune-oncology challenges 08 December, 2016 Peter Johnson works at the Experimental Cancer Medicine Centre and is a professor at the University of Southampton; he talks to Kerry Taylor-Smith about minimising operational...

Collaboratively speaking – comparator supply 08 December, 2016 Collaboration isn’t a word often associated with big pharma, with rival enterprises often seeking to block or delay the use of their products as comparator drugs. However, companies...

All together now – harmonising clinical trial regulation 08 December, 2016 The impact of international regulation changes in the harmonisation of global requirements is a huge issue in clinical trials. Clinical Trials Insight speaks to Dr Robert Temple,...

Go the extra mile – shipment temperature monitoring 08 December, 2016 How do you overcome the challenges of the very end of the clinical supply chain and ensure temperature is maintained through to destination? Julian Piallat, R&D global...

Volunteer support – the power of decentralised trials 08 December, 2016 Technology’s reach extends beyond the boundaries of geography and captures a virtual globe. The rise of social media as a recruitment tool has proved a boon and a burden to the...

A matter of degrees – cold chain management 08 December, 2016 Rapid globalisation and the rise of temperature-sensitive modern drugs have made cold chain management a priority for pharmaceutical companies. Eva-Lotta Persson, research and...

Put patients first – increasing awareness of clinical trials 08 December, 2016 How do clinical trials guarantee they have enough participants while meeting tight deadlines? Pharma expert Narinder Chopra considers the benefits of increasing awareness of...

Better together – working with CMOs 08 December, 2016 Pharma firms often rely on CMOs for clinical trials materials. Elly Earls speaks to CRO-Consulting’s co-founder, Phil Burns, and Eric Langer, president and managing partner of...

Nothing to hide – medical writing and trial records 08 December, 2016 Staying on the right side of the regulations governing medical writing and trial records is an increasingly complex business. Christopher Marshallsay, director and head of medical...

Second skin – wearable drug delivery 26 October, 2016 A variety of new polymers and other materials created in the past few years are offering new options for drug delivery, enabling new solutions, such as wearables that medicate the...

Ingredients for success – challenges facing API manufacturers 19 September, 2016 While still a vibrant and growing sector, API manufacturers faces a number of challenges from tightened regulations to higher manufacturing costs and increased competition. Where...

The changing face of product identity 19 September, 2016 Internal capacity gaps need to be solved with the right outsourcing strategy. Kerry Taylor-Smith explains how document-centric organisations can switch to an information-centric setup...


View all features A-Z


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.
cachename:Featurescachekey:rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_-1676441643